March 29th 2023
Co-editor-in-Chief Howard S. Hochster, MD, highlights the most exciting developments from the 2023 Gastrointestinal Cancer Symposium hosted by the American Society of Clinical Oncology (ASCO).
January 25th 2023
Association of Aspirin Use With Mortality Risk Among Older Adult Patients with CancerDecember 27th 2019
The use of aspirin 3 or more times a week was associated with a reduction in all-cause, cancer, gastrointestinal cancer, and colorectal cancer mortality in adults 65 and over, according to a study published in JAMA Network Open.
FDA Grants Priority Review to Pemigatinib for SubgroupDecember 2nd 2019
The FDA has granted a priority review to a new drug application for pemigatinib as a treatment for patients with previously treated, locally advanced or metastatic cholangiocarcinoma with FGFR2 fusions or rearrangements.
Active Choice Intervention in EHR Is Effective for Clinician Ordering of Screening TestsNovember 18th 2019
A quality improvement study indicated that nudges in the electronic health record were associated with a significant increase in clinician ordering of screening tests for breast and colorectal cancer.
Evolving Strategies for the Management of BRAF-Mutant Metastatic Colorectal CancerJune 19th 2019
In this article, we review the characteristics of the BRAF mutation and the evolving strategies for managing BRAF-mutant metastatic colorectal cancer.
Evaluating Immunotherapy in Nonmetastatic Colorectal CancerMay 14th 2019
Dr. Sinicrope reviews the phase III ATOMIC trial, which is testing standard chemotherapy alone or in combination with the anti–PD-L1 antibody atezolizumab as adjuvant therapy in a subset of colon cancer patients.